Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center Identifier:
First received: January 28, 2000
Last updated: June 18, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2000
  Primary Completion Date: August 2000 (Final data collection date for primary outcome measure)